Herpes Simplex Virus 1/2 (HSV1/2) IgG with Reflex to HSV-2 Inhibition
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms | |
| Cerner Primary Mnemonic | HSV-1,2 (IgG) w Rflx to HSV-2 Inhib |
| EPIC Display Name | Herpes Simplex Virus 1/2 (HSV1/2) IgG with Reflex to HSV-2 Inhibition |
| Allscripts (AEHR) Order Name | HSV-1,2 (IgG) w Rflx to HSV-2 Inhib |
| Sunrise Clinical Manager (SCM) Order Name | Not Orderable |
| EPIC Inpatient Orderable | Yes |
| EPIC Outpatient Orderable | Yes |
| Cerner Results |
HSV2IGGTSAB HSV1IGGTSAB |
| Clinical Info |
Herpes Simplex Virus 1 and 2 (IgG), with Reflex to HSV-2 Inhibition - Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis. There are two HSV serotypes that are closely related antigenically. HSV type 2 is more commonly associated with genital tract and neonatal infections, while HSV type 1 is more commonly associated with infections of non-genital sites. Specific typing is not usually required for diagnosis or treatment. The mean time to seroconversion using the type specific assay is 25 days. The performance of this assay has not been established for use in a pediatric population, for neonatal screening, or for testing of immunocompromised patients. |
| Specimen Type |
Blood |
| Container |
Gold Top Tube |
| Collection Instructions |
Container/Tube: Gold Top Tube Specimen: 2 mL serum (1 mL min) Transport Temperature: Room Temperature Stability: 7 Days Room Temperature 14 Days Refrigerated 30 Days Frozen |
| Transport Instructions |
Room Temperature |
| Specimen Stability |
7 Days Room Temperature 14 Days Refrigerated 30 Days Frozen |
| Methodology |
Immunoassay (IA) |
| Days Performed |
TAT: 2 - 3 Days |
| Performing Laboratory |
Quest Diagnostics Nichols Institute, Chantilly, VA Herpes Simplex Virus 2 (IgG) is >1.09, then HSV-2 Inhibition Study will be performed at an additional charge (CPT code(s): 86696). |
| CPT |
86695 86696 |
| PDM |
2159704 |
Desired Epic Build Herpes Simplex Virus 1/2 (HSV1/2) IgG with Reflex to HSV-2 Inhibition
| Cerner Primary Mnemonic: | HSV-1,2 (IgG) w Rflx to HSV-2 Inhib | |||||||||
| PDM | 2159704 | |||||||||
| Informatics - Workgroup | Infectious Disease | |||||||||
| Synonyms * | ||||||||||
| Display Name * | Herpes Simplex Virus 1/2 (HSV1/2) IgG with Reflex to HSV-2 Inhibition | |||||||||
| Order Entry Specimen Sources * | ||||||||||
| Order Entry Specimen Types | ||||||||||
| Specimen Navigator Specimen Types | ||||||||||
| Specimen Navigator Specimen Sources | ||||||||||
| Specimen Navigator Short Name | ||||||||||
| Ordering info (EPIC SmartText) | Herpes Simplex Virus 1 and 2 (IgG), with Reflex to HSV-2 Inhibition - Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis. There are two HSV serotypes that are closely related antigenically. HSV type 2 is more commonly associated with genital tract and neonatal infections, while HSV type 1 is more commonly associated with infections of non-genital sites. Specific typing is not usually required for diagnosis or treatment. The mean time to seroconversion using the type specific assay is 25 days. The performance of this assay has not been established for use in a pediatric population, for neonatal screening, or for testing of immunocompromised patients. | |||||||||
| IP Orderable | Yes | |||||||||
| OP Orderable | Yes | |||||||||
|
AOEs * | ||||||||||
| AP AOEs | ||||||||||
| Special History | No | |||||||||
| Build Comments | ||||||||||
| Filter * | ||||||||||
| Procedure Category Change | ||||||||||
Cerner Results
| ||||||||||
Current Actual EPIC Build as of 10/28/2024
| Procedure Id | 185173 | ||||||||||||||||||
| Pdm | 2159704 | ||||||||||||||||||
| Order Display Name | Herpes Simplex Virus 1/2 (HSV1/2) IgG with Reflex to HSV-2 Inhibition | ||||||||||||||||||
| Procedure Name | HERPES SIMPLEX VIRUS 1/2 IGG WITH REFLEX TO HSV-2 INHIBITION | ||||||||||||||||||
| Procedure Master Number | LAB14289 | ||||||||||||||||||
| Short Procedure Name | HERPES SIMPLEX VIRUS 1/2 IGG WITH REFLEX TO HSV-2 INHIBITION | ||||||||||||||||||
| Category Code | 1.0 | ||||||||||||||||||
| Category Code Record Name | LAB BLOOD ORDERABLES | ||||||||||||||||||
| Synonyms | HSV12IN | ||||||||||||||||||
| Clinically Active | Yes | ||||||||||||||||||
| Orderable | Yes | ||||||||||||||||||
| Performable | Yes | ||||||||||||||||||
| Filter Genomics | |||||||||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/185173 | ||||||||||||||||||
| Ordering Instructions | |||||||||||||||||||
| Default Specimen Type | Blood | ||||||||||||||||||
| Specimen Type Pick List | Blood | ||||||||||||||||||
| Specimen Type List | |||||||||||||||||||
| Op Specimen Type List | |||||||||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||||||||
| Specimen Source Default - Male | Blood, Venous | ||||||||||||||||||
| Specimen Source Default - Female | Blood, Venous | ||||||||||||||||||
| Specimen Source List | |||||||||||||||||||
| Op Specimen Source List | |||||||||||||||||||
| Ip Lab Test Components For Report | |||||||||||||||||||
| Op Lab Test Components For Report | |||||||||||||||||||
| Order Questions | [] | ||||||||||||||||||
| Order Questions Record Name | |||||||||||||||||||
| Inpatient Order Questions | [] | ||||||||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||||||||
| Order Specific Question Override | |||||||||||||||||||
| Inpatient Question Override | |||||||||||||||||||
| Location Restrict List Ip | |||||||||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||||||||
| Location Restrict List Include Ip | |||||||||||||||||||
| Location Restrict List Op | |||||||||||||||||||
| Location Restrict List Op Record Name | |||||||||||||||||||
| Location Restrict List Includes Op | |||||||||||||||||||
| Edp Amb Order Specific Questions Record Name | |||||||||||||||||||
| Edp Ip Order Specific Questions Record Name | |||||||||||||||||||
| Edp Ip Specimen Source | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary | ||||||||||||||||||
| Edp Op Specimen Source | |||||||||||||||||||
| Edp Ip Specimen Type | Blood | ||||||||||||||||||
| Edp Op Specimen Type | |||||||||||||||||||
| Derived Edp Ip Buttons S | Blood, Central Line Blood, Venous Blood, Capillary Blood, Arterial | ||||||||||||||||||
| Derived Edp Ip Buttons T | Blood | ||||||||||||||||||
| Derived Edp Op Buttons S | |||||||||||||||||||
| Derived Edp Op Buttons T | |||||||||||||||||||
| Ip Orderable | 0 | ||||||||||||||||||
| Op Orderable | 0 | ||||||||||||||||||
| EPIC OP AOEs | |||||||||||||||||||
| EPIC IP AOEs | |||||||||||||||||||
EPIC Components (results)
| |||||||||||||||||||